Tribulus Terrestris Side Effects

Reported Tribulus Terrestris side effects

Tribulus terrestris is generally well-tolerated at typical doses of 250-1500mg/day of standardized extract for durations of up to 12 weeks in most clinical trials, but several safety considerations warrant attention. Common mild side effects (≥1% incidence in clinical trials): Gastrointestinal symptoms: Nausea, cramping, diarrhea, reflux, and abdominal discomfort are the most common complaints, particularly at higher doses or when taken on an empty stomach. Taking Tribulus with food substantially reduces GI side effects. Sleep disturbance: Some users report restlessness, insomnia, or vivid dreams, particularly with evening dosing. These effects may reflect the mild MAO-inhibitory activity of beta-carbolines in the plant. Headache: Mild headache is occasionally reported, possibly related to vascular effects. Increased urinary frequency: The diuretic effect of Tribulus produces increased urination in many users, which is expected rather than pathological but can be inconvenient. Less common but more concerning adverse effects: Hepatotoxicity (liver injury): A growing cluster of case reports in the hepatology literature describes Tribulus-associated drug-induced liver injury (DILI), with patterns ranging from mild asymptomatic transaminitis to more clinically significant hepatocellular injury. Not all cases can be definitively attributed to Tribulus (multi-supplement use complicates causality), but the number of reports has risen to the point where the LiverTox database (NIH's clinical reference for drug-induced liver injury) includes Tribulus. Users with pre-existing liver disease, those taking hepatotoxic medications, or those using Tribulus in combination with multiple other supplements should be particularly cautious. Baseline and follow-up liver function tests (AST, ALT, bilirubin) are reasonable for extended use. Gynecomastia in men: Case reports of gynecomastia (breast tissue development) in men using Tribulus — particularly at high doses or in combination with other hormonally active supplements — have been published. The mechanism is unclear given the generally null testosterone/estradiol findings in clinical trials; possible explanations include individual variation, aromatase modulation, or adulteration with actual hormonal agents in some products. Priapism and prolonged erections: Rare reports of priapism (painful, prolonged erection lasting >4 hours), particularly when Tribulus is combined with PDE5 inhibitors (sildenafil, tadalafil) or with other pro-erectile agents. Priapism is a urologic emergency requiring prompt medical attention. Cardiovascular events: A notorious cluster of myocardial events (angina, myocardial infarction) reported from Iran and other regions has raised concerns, though definitive causality has not been established. Proposed mechanisms include vasoactive effects of saponins, contamination/adulteration, or use in underlying atherosclerotic disease. Patients with known or suspected cardiovascular disease should consult a physician before use. Blood pressure effects: Reports of both blood pressure elevation and reduction exist, with individual variation apparently high. Users with hypertension, hypotension, or on blood pressure medications should monitor accordingly. Population-specific concerns: Pregnancy and lactation: Contraindicated. Tribulus has uterotonic effects in animal models and theoretical abortifacient potential. Lactation safety data is absent. Avoid. Hormone-sensitive cancers (prostate, breast, ovarian, endometrial): Given the uncertain but possible hormonal effects and case reports of gynecomastia, patients with current or historical hormone-sensitive cancers should avoid Tribulus or use only under oncological guidance. Prostate conditions: BPH patients and those with prostate cancer should avoid due to theoretical androgen-adjacent effects and potential for complicating urological diagnosis and treatment. Children and adolescents: Not studied, not recommended. Liver disease: Use with caution or avoid given hepatotoxicity signal; monitor LFTs if used. Kidney disease: Despite traditional "kidney support" claims, Tribulus's diuretic effects and unknown interactions with renal medications warrant caution in chronic kidney disease. Drug interactions: PDE5 inhibitors (sildenafil, tadalafil, vardenafil): Additive pro-erectile effects may increase priapism risk. Use with caution or under medical supervision. Antihypertensive medications: Unpredictable effects on blood pressure may interact with antihypertensive therapy; monitor blood pressure. Anticoagulants and antiplatelet agents: Possible additive effects on bleeding risk through modest antiplatelet activity. Monitor if combined. Lithium: Tribulus's diuretic effects could theoretically alter lithium clearance and affect serum lithium levels; monitor. Diabetes medications: Possible additive hypoglycemic effects; monitor blood glucose when combined with insulin or oral diabetes medications. Immunosuppressants: Tribulus may modestly enhance immune function, which could theoretically interfere with immunosuppression in transplant recipients or autoimmune disease management. Monoamine oxidase inhibitors (MAOIs): The beta-carboline content of Tribulus includes weak MAO inhibitors; combining with pharmaceutical MAOIs is theoretically risky and should be avoided. Quality and adulteration considerations: Pharmaceutical steroid adulteration: Tribulus supplements have been repeatedly found adulterated with anabolic-androgenic steroids, designer steroids, or prohormones — particularly those marketed aggressively for testosterone or muscle gain. Users experiencing dramatic effects (that the herb pharmacologically cannot produce) should suspect adulteration. PDE5 inhibitor adulteration: Products marketed for erectile function have been found containing undeclared sildenafil, tadalafil, or their analogs. This is both illegal and potentially dangerous (particularly in combination with nitrates). Heavy metal contamination: Tribulus, like many herbs, can accumulate heavy metals from soil. Third-party tested products reduce this risk. Users should preferentially choose products with independent third-party testing (USP Verified, NSF Certified for Sport, Informed Choice, ConsumerLab) to minimize adulteration and contamination risks.

When to continue, reduce, or stop Tribulus Terrestris

Tribulus Terrestris contraindications

Tribulus terrestris is contraindicated or requires special caution in the following circumstances: Absolute contraindications: Pregnancy: Contraindicated. Tribulus has uterotonic effects in animal models and theoretical abortifacient potential. Animal studies at high doses have shown adverse reproductive outcomes. Avoid throughout pregnancy. Lactation: Contraindicated. Safety data in nursing mothers is absent; infant exposure through breast milk has not been studied. Avoid during breastfeeding. Children and adolescents (under 18): Contraindicated. Hormonal effects of concern in developing individuals; no safety or efficacy data in pediatric populations. Hormone-sensitive cancers (active): Prostate cancer, hormone-sensitive breast cancer, ovarian cancer, endometrial cancer. Tribulus's possible (though uncertain) hormonal effects and the case reports of gynecomastia in users raise concerns about interference with hormone-sensitive disease. Avoid unless explicitly directed by oncologist. Active liver disease: Given the growing cluster of hepatotoxicity case reports, patients with active hepatitis, cirrhosis, NAFLD with significant enzyme elevation, or other liver disease should avoid. Recent myocardial infarction or unstable angina: Case reports of cardiovascular events associated with Tribulus use, combined with the pro-contractility effects noted in some studies, warrant avoidance in acute/unstable cardiovascular disease. Strong cautions (use only under medical supervision): History of prostate cancer or elevated PSA: Theoretical concern about androgen-adjacent effects; consultation with urology/oncology recommended. BPH (benign prostatic hyperplasia) with significant symptoms: Urinary effects may complicate BPH symptoms; coordinate with urologist. Hormone-sensitive conditions (endometriosis, uterine fibroids, PCOS): Unpredictable hormonal effects warrant caution. Cardiovascular disease: Coronary artery disease, heart failure, arrhythmias — given the cardiovascular adverse event signal, consult cardiologist before use. Hypertension or hypotension: Unpredictable blood pressure effects; monitor if used. Diabetes: Possible hypoglycemic effects warrant blood glucose monitoring when combined with insulin or oral diabetes medications. Chronic kidney disease: Despite traditional "kidney support" claims, safety in renal impairment is not established; caution advised. Psychiatric conditions: Reports of agitation, anxiety, and insomnia warrant caution in patients with anxiety disorders, bipolar disorder, or psychotic disorders. Bleeding disorders or upcoming surgery: Possible antiplatelet effects; discontinue at least 2 weeks before elective surgery. Drug interactions warranting caution or avoidance: Testosterone replacement therapy (TRT): Theoretical redundancy and complication of hormone monitoring; not recommended to combine unless under medical guidance. Anabolic-androgenic steroids (whether medical or non-medical): Do not combine; risk of additive hormonal effects. PDE5 inhibitors (sildenafil/Viagra, tadalafil/Cialis, vardenafil/Levitra, avanafil/Stendra): Potential additive pro-erectile effects; increased priapism risk. Use with caution and at minimum effective doses. Pharmaceutical MAOIs (selegiline, rasagiline, phenelzine, tranylcypromine, moclobemide): Theoretical additive MAO inhibition through beta-carbolines; avoid combination. Anticoagulants (warfarin, DOACs like apixaban/rivaroxaban): Possible additive bleeding risk; monitor INR if on warfarin. Antiplatelets (aspirin, clopidogrel, ticagrelor, prasugrel): Additive effects; monitor for bleeding. Antihypertensives (all classes): Unpredictable effects on blood pressure; monitor. Lithium: Tribulus's diuretic effect could alter lithium clearance; monitor serum lithium. Diabetes medications (insulin, sulfonylureas, metformin): Possible hypoglycemic effects; monitor blood glucose. Immunosuppressants (cyclosporine, tacrolimus, corticosteroids used for transplantation or autoimmune disease): Possible immunomodulatory effects of concern in immunocompromised individuals. Hepatotoxic medications (acetaminophen in high doses, methotrexate, isoniazid, amiodarone, some antiepileptics, statins in susceptible individuals): Potential additive hepatotoxicity; use with particular caution. Other hepatotoxic herbal products (kava, high-dose green tea extract, pennyroyal, comfrey, chaparral, germander): Avoid stacking multiple potentially hepatotoxic agents. Quality-related contraindications: Products without third-party testing: Adulteration risk makes non-certified Tribulus products inappropriate for anyone with competitive drug testing obligations (athletes, law enforcement, military). "Proprietary blend" or multi-ingredient testosterone booster products: Cannot verify actual Tribulus dose or ingredient identity; often contain problematic co-ingredients (DHEA without disclosure, pharmaceutical adulterants, etc.). Extreme-claim products: Products promising dramatic muscle gain, specific testosterone elevation numbers, or "legal steroid" effects should be avoided as likely adulterated or fraudulent. Populations where Tribulus is particularly unsuitable: Young healthy eugonadal men seeking "testosterone boost" — evidence does not support the claimed benefit; lifestyle optimization is more effective. Athletes competing under WADA or similar drug testing rules — adulteration risk is too high; prefer well-studied alternatives without testing issues. Individuals with chronic hepatitis or NAFLD — hepatotoxicity signal warrants avoidance. Individuals on complex medication regimens — interaction potential compounds with each added medication. When to discontinue: New or worsening jaundice, dark urine, light-colored stools, or upper right abdominal pain (possible hepatotoxicity) New chest pain, dyspnea, palpitations, or cardiovascular symptoms Prolonged erection (>4 hours — priapism is a urologic emergency) Gynecomastia development in men Significant mood or mental health changes Any acute allergic reaction Any adverse effect severe enough to disrupt daily functioning

Why vendor quality drives Tribulus Terrestris side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

Tribulus Terrestris side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .